Evidence map›Paper›PMID 40736088›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2025

3D Printing for Neural Repair: Bridging the Gap in Regenerative Medicine.

Mitchell St Clair-Glover, Zhilian Yue, Mirella Dottori

Abstract read
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Development of aBioactive materials · 2026
    Article
  3. Article
  4. 3D Printing for Neural Repair: Bridging the Gap in Regenerative Medicine.Advanced materials (Deerfield Beach, Fla.) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mitchell St Clair-GloverSchool of Medical Indigenous and Health Sciences, Molecular Horizons, University of Wollongong, Wollongong, NSW, 2522, Australia.ORCID 0000-0001-8095-0927
Zhilian YueIntelligent Polymer Research Institute, Faculty of Engineering and Information Science, University of Wollongong, Innovation Campus, North Wollongong, NSW, 2500, Australia.ORCID 0000-0003-1258-8748
Mirella DottoriSchool of Medical Indigenous and Health Sciences, Molecular Horizons, University of Wollongong, Wollongong, NSW, 2522, Australia.ORCID 0000-0003-0598-4195

Funding

Australian Government Research Training Program (RTP) ScholarshipAustralian National Fabrication FacilityAustralian Research Council LP190101139Australian Research Council Discovery Projects DP230101369Australian Research Council Discovery Projects DP240102511Australian Rotary HealthCentre of Excellence for Electromaterials Science, Australian Research Council CE140100012Friedreich Ataxia Research Association AustraliaFriedreich's Ataxia Research AllianceIllawarra Health and Medical Research Institute (past)University of WollongongWest Wollongong Rotary Club
6 · The paper itself

Abstract

Neurological disorders impose a substantial global health burden, compounded by the limited regenerative capacity of neural tissues and the absence of curative therapies. 3D bioprinting offers a transformative tool to model, replace, and regenerate neural tissues through the precise spatial organization of cells and biomaterials. In this perspective article, recent advances are examined in: i) the development of in vitro neural platforms for disease modeling and drug screening; ii) bioprinted acellular scaffolds designed to guide endogenous neural repair; and iii) cell-laden constructs that aim to replace or reconstruct damaged neural circuits. Key translational challenges are critically evaluated, including vascularization, immune integration, functional maturation, and replicating the complex cytoarchitectures of native neural tissues. Highlighting representative preclinical studies and emerging biofabrication technologies, we discuss how innovations in biomaterials, scaffold design, stem cell biology, and neuroengineering are converging to overcome existing limitations. Through tailored strategies and interdisciplinary collaboration, 3D bioprinting is poised to redefine therapeutic paradigms and drive the development of next-generation, personalized regenerative therapies for neurological diseases and injuries.

Indexed as

Nerve RegenerationPrinting, Three-DimensionalRegenerative MedicineAnimalsBiocompatible MaterialsBioprintingHumansTissue EngineeringTissue ScaffoldsBiocompatible Materialsbiomaterialsbioprintingneural repairneuronsneuroscienceregenerative medicinestem cells

Identifiers

PMID40736088
PMCPMC12422090

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.